9 Jefferies Group Argen X SE Trades
Jefferies Group's position in Argen X SE is currently worth $114M. That's 1.94% of their equity portfolio (6th largest holding). The first Argen X SE trade was made in Q2 2023. Since then Jefferies Group bought shares six more times and sold shares on two occasions. The stake costed the investor $73.6M, netting the investor a gain of 55% so far.
Avg closing price
Price range
Sold 28.1% shares (-60.6k shares)
Q2 2025
Avg closing price
$580.30
Price range
$532.27
-
$656.65
Increased shares by 0.1% (+248 shares)
Q1 2025
Avg closing price
$631.69
Price range
$571.00
-
$671.74
Increased shares by 34.8% (+55.8k shares)
Q4 2024
Avg closing price
$587.54
Price range
$520.52
-
$638.33
Increased shares by 319900.0% (+160k shares)
Q3 2024
Avg closing price
$504.47
Price range
$434.22
-
$552.56
Sold 100.0% shares (-135k shares)
Q2 2024
Avg closing price
$382.76
Price range
$356.01
-
$451.55
Increased shares by 4372.0% (+132k shares)
Q1 2024
Avg closing price
$387.40
Price range
$356.95
-
$413.29
Increased shares by 51.1% (+1.02k shares)
Q4 2023
Avg closing price
$465.95
Price range
$338.91
-
$506.01
Increased shares by 166.7% (+1.25k shares)
Q3 2023
Avg closing price
$489.17
Price range
$369.35
-
$548.43
New holding (+750 shares)
Q2 2023
Avg closing price
$393.32
Price range
$360.14
-
$422.58
News about Argen X SE - ADR and Jefferies Group
Why Is Dutch Pharma Argenx Trading Lower Today?
Tuesday, Argenx SE (NASDAQ: ARGX ) released topline results from the ADVANCE-SC study evaluating Vyvgart Hytrulo (efgartigimod alfa and hyaluronidase-qvfc) i...
Argen X SE - ADR Shares Close in on 52-Week High - Market Mover
Argen X SE - ADR (ARGX) shares closed today at 1.9% below its 52 week high of $356.78, giving the company a market cap of $17B. The stock is currently down ...